New Mexico Cannabis Weekly

New Mexico Cannabis WeeklyCannabis, Psychedelics, the Vice Vertical & Emerging Markets

Issue No. 1 · Week Ending August 31, 2026
Published by High 5 Edibles Inc.

Why We’re Doing This

New Mexico’s cannabis industry is too interconnected for important information to sit behind scattered paywalls, newsletters and subscription services.

High 5 is launching New Mexico Cannabis Weekly as a free resource for the entire New Mexico cannabis community.

Each week, we’ll monitor regulatory updates, industry publications, market data, legal developments and emerging sectors, then distill the information that matters most to operators, retailers, producers, patients and anyone trying to understand where this industry is going. We’ll credit and link to the original reporting whenever possible.

No subscription. No paywall. No membership required.

Just useful information, freely available to the New Mexico cannabis community. Because a better-informed industry is a stronger industry.

New Mexico cannabis enters September with one of the industry’s most consequential operational changes since adult-use legalization: the replacement of BioTrack with the state’s new NMS2S track-and-trace platform.

At the same time, operators have gone to court seeking to slow that transition, cannabis sales remain strong, competition is reshaping even the state’s cannabis-banking business, and New Mexico’s new medical psilocybin industry is beginning to move from legislation into actual operations.

Here is what matters this week.

The Big Story

Cannabis Operators Go to Court Over NMS2S Rollout

A coalition of New Mexico cannabis businesses, supported by the Cannabis Association of New Mexico, filed for emergency injunctive relief on August 21 seeking to prevent the Cannabis Control Division from fully shutting down BioTrack before its replacement, NMS2S, has been proven operational.

The operators are not asking the state to abandon NMS2S. Their position is considerably narrower: keep the existing BioTrack system available while the replacement is fully tested, documented and demonstrated to function without materially disrupting the legal cannabis supply chain.

The lawsuit raises concerns about interruptions to testing, transfers, inventory receiving, compliance and cash flow, as well as the timing of training materials and third-party system integrations.

MMJDaily highlighted the dispute in its August 25 report, “New Mexico cannabis operators seek injunction to block NMS2S rollout before BioTrack shutdown.”

A subsequent MMJDaily report published August 31 said the state filed a motion to dismiss on August 24. As of the latest reported court status, no ruling on the requested emergency relief had been reported.

Why Operators Are Concerned

The transition overlaps the beginning of New Mexico’s fall harvest and wholesale cycle and temporarily restricts some of the activities manufacturers, producers, laboratories and retailers depend upon to move products through the regulated market.

The plaintiffs argue that taking a functioning compliance system offline before the replacement has been fully proven creates unnecessary operational risk. CCD, meanwhile, maintains that NMS2S has been under development and testing and that the concentrated transition schedule is intended to allow technical teams and support resources to focus on the cutover.

This is a supply-chain, regulatory and business-continuity story for virtually every licensed cannabis company in New Mexico.

The NMS2S Clock Is Running

Regardless of the court challenge, CCD’s published transition schedule remains in effect unless something changes.

August 25

BioTrack functionality ended for non-retail licensees after 5:00 p.m. Testing laboratories were unable to receive new samples during the migration period.

August 31

Non-retail licensees are scheduled to gain access to migrated inventory in NMS2S. Testing can resume. Producers and manufacturers should review their migrated inventory and reconcile any activity occurring during the transition.

September 1

Retail inventory migration begins. Retail sales remain on BioTrack during this portion of the transition.

September 2

Retailers are scheduled to gain access to NMS2S while continuing sales through BioTrack until final cutover.

September 4 — 12:01 a.m.

BioTrack is scheduled to be turned off completely. All regulated cannabis activity, including retail sales, moves to NMS2S.

This Week’s Operator Priority

Reconcile everything: plants, packages, harvests, transfers, finished inventory, retail inventory and outstanding transactions. The quality of the data entering the new system may be just as important as the software itself.

Market Pulse

New Mexico Cannabis Demand Remains Strong

New Mexico retailers generated approximately $49.8 million in combined cannabis sales during July 2026: about $39.6 million adult-use and $10.2 million medical. July’s adult-use total set a new monthly record for New Mexico.

The state recorded more than 1.25 million cannabis transactions during the month, and cumulative legal cannabis sales have surpassed $2.4 billion. Through the first half of 2026 alone, New Mexico retailers generated approximately $284.9 million in combined medical and adult-use sales.

The Market Is Maturing

The numbers tell two stories at once. Consumer demand remains strong. Operator economics remain difficult.

New Mexico is increasingly behaving like other mature cannabis markets: intense competition, price pressure, consolidation and an increasing premium on efficiency. Simply being licensed is no longer a competitive advantage.

The Texas Effect

Border Markets Continue to Reshape New Mexico Cannabis

New Mexico’s geography gives it something most legal cannabis markets do not have: Texas.

Sunland Park continues to generate extraordinary cannabis sales for a city of its size. During the second quarter, Sunland Park generated roughly $5.3 million to $5.8 million per month, making it one of the strongest cannabis markets in New Mexico. Cumulative sales in Sunland Park have surpassed $204 million. Chaparral and Santa Teresa also continue generating meaningful cannabis activity along the Texas border.

Texas prohibition remains an economic tailwind for southern New Mexico cannabis.

Cannabis Banking Gets Competitive

U.S. Eagle Exits the Market — Because There Are More Options

U.S. Eagle Federal Credit Union announced that its Aery Group cannabis-banking operation will close effective November 1. Aery launched in 2019 and was among the early financial institutions willing to serve New Mexico cannabis companies.

U.S. Eagle cited increased banking competition, industry consolidation and the strategic direction of the credit union among the reasons for leaving the business. Industry reporting indicates numerous other financial providers now work with New Mexico cannabis businesses.

Cannabis banking remains complicated federally, but New Mexico has moved from “Will anybody bank us?” toward “Which cannabis bank should we use?” That is another sign of a maturing industry.

Psilocybin Watch

New Mexico Is Building Its Next Regulated Market

The state’s Medical Psilocybin Act became law in 2025, establishing a regulated medical framework for psilocybin treatment. On August 17, 2026, the New Mexico Department of Health began accepting applications from prospective psilocybin producers.

That represents a major transition: Law → Regulation → Licensing → Operations.

What Producers Will Do

Permitted producers will form the regulated supply chain for naturally derived psilocybin products used in New Mexico’s medical program. Applicants face requirements involving business registration, facilities, zoning, safety, production, testing, traceability and other regulated activities.

Who May Qualify

The program is being developed for qualifying patients with conditions including treatment-resistant depression, post-traumatic stress disorder, substance-use disorders and end-of-life care. New Mexico’s Department of Health says its goal is to enroll the first patients by the end of December 2026.

This Is Not Recreational Legalization

New Mexico has not created recreational mushroom stores. The law establishes controlled medical access involving qualified patients, regulated products, professionals and approved locations. Commercially, however, an entirely new regulated ecosystem is being assembled.

Psilocybin Rulemaking

The Details of the Market Are Being Written Now

On August 24, the Department of Health published additional proposed rules governing major portions of the Medical Psilocybin Program. Those rules address patient enrollment, certifying clinicians, practitioners, facilitators, education and training programs, approved treatment locations, producer requirements and laboratory requirements.

The legislation created the opportunity. The rules determine what the business actually looks like.

Why Cannabis Operators Should Pay Attention

Cannabis and medical psilocybin are not the same industry, and a cannabis license does not authorize psilocybin activity. But the emerging psilocybin sector will require capabilities New Mexico cannabis operators already understand:

• Controlled cultivation

• Processing and manufacturing

• Laboratory testing

• Traceability and inventory controls

• Packaging and labeling

• SOP development

• Facility compliance and state inspections

• Product consistency and regulatory documentation

The experience accumulated through more than a decade of regulated cannabis in New Mexico could become valuable institutional knowledge as this next regulated market develops.

The Vice Vertical

Regulation Is Becoming a Business Category of Its Own

Cannabis is increasingly part of a much larger economic category: businesses whose products or services exist at the intersection of consumer demand, regulation, taxation, public policy and changing social attitudes.

Cannabis sits there. Psychedelics increasingly sit there. Hemp-derived intoxicants, functional beverages and other emerging product categories are forcing regulators and businesses nationwide to confront many of the same questions.

That is why New Mexico Cannabis Weekly will look beyond cannabis itself. We will follow the Vice Vertical — regulated and emerging industries where changing law creates new markets, destroys old assumptions and generates new opportunities.

The goal is not hype. The goal is to see where the market is going before everybody else gets there.

New Mexico vs. the Nation

How Does Our Cannabis Market Stack Up?

New Mexico is small in absolute population but substantial in cannabis activity. The Census Bureau estimates New Mexico’s population at approximately 2.13 million people, yet July cannabis sales approached $50 million.

For context, selected legal markets recently reported monthly cannabis sales of approximately:

• Michigan — $270.9 million

• Massachusetts — $161.5 million

• Oregon — $79.5 million

• New Mexico — $49.8 million

• Montana — $29.7 million

Reporting periods and regulatory structures vary by state, so these are useful benchmarks rather than perfect apples-to-apples rankings.

What Makes New Mexico Different?

• Population: Small

• Demand: Strong relative to the state’s size

• Competition: Intense

• Pricing pressure: Significant

• Border demand: Unusually important

• Market maturity: Increasing rapidly

Nationwide, active cannabis business licenses declined for a seventh consecutive quarter in the first quarter of 2026. The national total was roughly 9% below its level two years earlier. The industry is shifting from a race to obtain licenses toward a race to build sustainable businesses. New Mexico is already there.

This Week’s Read

• New Mexico Demand: ▲ Strong

• Adult-Use Sales: ▲ Record July

• Medical Market: ▼ Smaller share of total sales

• Competition: ▲ Intense

• Operator Pressure: ▲ High

• National Environment: Consolidating

• New Emerging Market: Psilocybin

• Wild Card: Texas

• Immediate Risk: NMS2S transition

Bottom Line

New Mexico will never lead the United States in cannabis revenue by raw dollars. It doesn’t have to. For a state with roughly 2.1 million residents, New Mexico has built an unusually active cannabis economy, strengthened further by its proximity to Texas.

The challenge now is no longer creating the market. It is surviving, differentiating and making money inside it.

What We’re Watching Next Week

• Any court ruling in the NMS2S litigation

• September 4 BioTrack shutdown and NMS2S system performance

• POS and API integrations

• Testing, transfer and inventory reconciliation disruptions

• CCD bulletins and enforcement guidance

• Cannabis sales, pricing, openings, closures and acquisitions

• Cannabis banking changes

• Psilocybin producer applications and rulemaking

• Federal cannabis policy and emerging Vice Vertical markets

The High 5 Perspective

New Mexico cannabis is entering its next phase. The easy-growth period is over.

The market is larger, more sophisticated and more competitive. Regulatory systems are changing. Prices remain under pressure. Businesses are consolidating. New industries such as medical psilocybin are emerging beside cannabis.

For operators, that creates pressure. For well-run companies, it creates opportunity.

At High 5 Edibles Inc., we have spent more than a decade working inside New Mexico’s regulated cannabis industry through its growth, its regulatory changes and its changing economics.

This publication is about understanding what comes next. Not rumors. Not hype. The market, the regulations, the numbers and the opportunities that matter to New Mexico.

See you next week.

NEW MEXICO CANNABIS WEEKLY
Cannabis, Psychedelics, the Vice Vertical & Emerging Markets
Published by High 5 Edibles Inc.